However, another recent meta-analysis from 2022, conducted in a mixed pediatric population (n = 1039 cases/894 controls; Egypt, Turkey, Chile, China, Ireland, Greece, Tunisia, Cyprus and the United States), associates the dominant and additive models of the VDR FokI polymorphism with a lower risk of developing asthma (p = 0.004; OR = 0.67; 95% CI = 0.51–0.88; I2 = 11.6%; p(I2) = 0.34; TT + CT vs CC and p = 0.015; OR = 0.63; 95% CI = 0.43–0.92; I2 = 62.7%; p(I2) = 0.03; T vs. C, respectively) [57]. Here, VDR is linked to asthma.